Locate providers:   

Improve Facial Volume and Skin Laxity with ePrime from Syneron

 

Using a very small needle, physicians can improve skin volume with the new ePrime from Syneron.

The ePrime minimally invasive device from Syneron is enabling physicians to deliver measured Radio Frequency (RF) energy directly into the deep dermis for dramatic improvements of the skin in just one treatment. The device uses a small needle injected under the skin and delivers RF energy directly to the deep dermis, sparing the outermost layer from any thermal damage and tightening the skin.

According to the manufacturer, this high-volume fractional injury to the deep dermis stimulates new growth of collagen and elastin and rushes more hyaluronic acid to the site. Physicians are better able to create zones of injury to the deep skin where it will have the most impact and create a more solid foundation of volume to build upon should patients desire a surface treatment for issues like skin discolorations.

eprime before and after
Actual results of ePrime, 3 months post-treatment
Photo courtesy of Syneron.com


New York dermatologist Dr. Macrene Alexiades-Armenakas says the ideal candidate for the ePrime treatment is someone with a more advanced level of skin laxity. "The best patient is typically one who has ruled out or is not quite ready for a surgical facelift but who is too far along for a skin surface technology. It is for the patient who needs a step-up from skin surfacing technologies in terms of efficacy, but who has already ruled out an invasive surgical facelift."

The temperature needed to bring about maximum results can be reached in a single treatment and the physician can monitor the temperature in real time to ensure patient safety. The ePrime device is designed to improve skin tone and skin volume regardless of skin conditions and skin type.

Dr. Alexiades-Armenakas said that when she was performing the clinical trials, she compared the results of the ePrime device to a standard facelift. "What we did during the trial was I randomized patients to the ePrime device vs. surgical facelifting and had baseline and follow up photos for both," she described. After randomizing and intermixing photos, she sent out the set for evaluation and grading by 5 other dermatologists and plastic surgeons. "The scoring was based on a 4 point scale and we were able to determine that the ePrime gave 37% of the result of a surgical facelift. Patients can enjoy about a third of the results of a surgical facelift in a single treatment with no scarring and very little downtime. This is a huge achievement."

She says there is still testing to be done on the ePrime and that next physicians seek to determine if additional treatments will yield better results. "We need to see whether three treatments in succession would actually approximate a facelift. I doubt we'll be able to accomplish that because we're up against a pretty heavy hitter. The surgical facelift is not just a skin tightening tool. It also includes lipectomy, which is the excision of fat from around the neck area, and that's something unachievable with a skin tightening technology. My expectation and my prediction is that we might get closer to 50% or so but we would max out at the point where the fat needs to be removed," says Dr. Alexiades-Armenakas.